Filing Flows › Health Care › Hims & Hers Health (HIMS)
Hims & Hers Health (HIMS) earnings and revenue breakdown
Latest: Q2 2026 · 10-Q filed Aug 10, 2026 · Hims & Hers Health (HIMS) Q2 2026 earnings results →
Q2 2026 Revenue up 38% year over year to $753M · 11¢ of every $1 of revenue lost · operating margin -12.9%
Hims & Hers Health made $753M in Q2 2026 (+38% Y/Y). Operating margin -12.9%, net loss $86.3M. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-Q filed Aug 10, 2026.
Drawing the Sankey…
Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF
What changed this quarter
Revenue was $753.2M in Q2 2026, up 38% year over year and up 24% from the previous quarter.
Gross margin was 63.8%, down 12.6 points from Q2 2025. Operating costs exceeded revenue by $97.2M, an operating margin of -12.9%. Operating expenses grew 48% against revenue growth of 38%. The fastest-growing cost line was General & admin (+146%). The quarter ended with a net loss of $86.3M, narrower than the previous quarter's $92.1M loss.
Operating cash flow was −$35.9M. Non-cash charges added back $29.5M of depreciation and amortization and $42.1M of share-based compensation. Working capital and other items used $21.2M. Capital expenditures of $32.3M exceeded it, leaving free cash flow of −$68.2M.
Quarterly history
| Quarter | Form | Filed | Revenue | Y/Y | Op. margin | Net earnings | Op. cash flow |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 10-Q | Aug 10, 2026 | $753M | +38% | -12.9% | −$86.3M | −$35.9M |
| Q1 2026 | 10-Q | May 11, 2026 | $608M | +4% | -12.9% | −$92.1M | $89.4M |
| Q4 2025 | 10-K | Feb 23, 2026 | $618M | +28% | 1.5% | $20.6M | $61.3M |
| Q3 2025 | 10-Q | Nov 3, 2025 | $599M | +49% | 2.0% | $15.8M | $149M |
| Q2 2025 | 10-Q | Aug 4, 2025 | $545M | +73% | 4.9% | $42.5M | −$19.1M |
| Q1 2025 | 10-Q | May 5, 2025 | $586M | +111% | 9.9% | $49.5M | $109M |
| Q4 2024 | 10-K | Feb 24, 2025 | $481M | +95% | 3.9% | $26.0M | $86.4M |
Charts
In supply chains and themes
Interactive views
The same charts as the app — open one to draw it.
💵Where each $1 goesinteractive
Loading the interactive chart…
🌏Named in Asian annual reportsinteractive
Loading the interactive chart…
🔄Rotation against the market and its industry (RRG)interactive
Loading the interactive chart…
🔍Earnings qualityinteractive
Loading the interactive chart…
⚖️Fair value by methodinteractive
Loading the interactive chart…
🔭Outlook & guidanceinteractive
Loading the interactive chart…
📈Investments: gains and what it boughtinteractive
Loading the interactive chart…
🏭Its industry’s money flow (input-output)interactive
Loading the interactive chart…
About Hims & Hers Health
Launched in 2017, Hims & Hers Health, Inc. (and together with its subsidiaries, “Hims & Hers”, the “Company”, “we”, “us” or “our”) has built a consumer-first platform transforming the way customers fulfill their health and wellness needs. We believe that the Company has the technical infrastructure, distributed provider network, and access to clinical capabilities to lead the migration of routine office visits to a personalized, digital, accessible format. The Hims & Hers platforms (collectively, our “platform”) include access to a highly-qualified and technologically-innovative provider network, an electronic medical record system designed to support providers and customers, digital prescriptions, cloud pharmacy fulfillment, and personalization capabilities.
In its own words, from its 10-K, filed Feb 23, 2026.
Hims & Hers Health against its Services-Offices & Clinics of Doctors of Medicine peers
The largest companies of the same SEC industry, each at its latest quarter. Revenue growth: +38% against the peers' median -3%. Operating margin: -12.9% against the peers' median -12.9%.
| Company | Quarter | Revenue | Y/Y | Op. margin |
|---|---|---|---|---|
| HIMS Hims & Hers Health | Q2 2026 | $753M | +38% | -12.9% |
| TDOC Teladoc Health | Q3 2026 | $605M | -3% | -4.6% |
| STLN Starling Oncology | Q3 2026 | $170M | +24% | -1.8% |
| SBC SBC Medical Group Holdings | Q2 2026 | $49.2M | +13% | 38.5% |
| LFMD LifeMD | Q2 2026 | $47.3M | -4% | -15.1% |
| AIRS Airsculpt Technologies | Q3 2026 | $31.9M | -9% | -13.0% |
| CDIX Cardiff Lexington | Q2 2026 | $2.2M | -23% | -25.2% |
| HLYK HealthLynked | Q2 2026 | $250K | -58% | -215.7% |
Source: Hims & Hers Health 10-Q on SEC EDGAR · CIK 1773751 · Services-Offices & Clinics of Doctors of Medicine
Guidance and outlook
13F: who owns HIMS and who is buying
More on HIMS
- How Hims & Hers Health makes money: revenue by segment
- Hims & Hers Health next earnings date and what analysts expect
- Hims & Hers Health stock forecast, price target and fair value
- Who owns Hims & Hers Health stock: holders, funds and Congress trades
- Is Hims & Hers Health a takeover target? LBO and rumors
History
Every quarter: Q2 2026 results · Q1 2026 results · Q4 2025 results · Q3 2025 results · Q2 2025 results · Q1 2025 results · Q4 2024 results